E-LIB Suche - Ergebnisse für: Hou, FF

1

Rationale and protocol of the Dapagliflozin And Prevention ..:

Heerspink, Hiddo J L ; Stefansson, Bergur V ; Chertow, Glenn M...
Nephrology Dialysis Transplantation. 35 (2020) 2 - p. 274-282 , 2020

Link: https://doi.org/10.1093/..

2

Successful treatment of massive ascites with intraperitonea..:

Zhou, QG ; Yang, XB ; Hou, FF.
Lupus. 18 (2009) 8 - p. 740-742 , 2009

Link: https://doi.org/10.1177/..

3

Induction treatment of proliferative lupus nephritis with l..:

Wang, HY ; Cui, TG ; Hou, FF...
Lupus. 17 (2008) 7 - p. 638-644 , 2008

Link: https://doi.org/10.1177/..

4

Dapagliflozin and new-onset type 2 diabetes in patients wit..:

Rossing, P ; Inzucchi, SE ; Vart, P...
https://discovery.ucl.ac.uk/id/eprint/10140959/1/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20T2D_LDE_revised_clean.pdf. , 2022

Link: https://discovery.ucl.ac..

5

Deep-learning models for the detection and incidence predic..:

Zhang, K ; Liu, X ; Xu, J...
doi:10.1038/s41551-021-00745-6. , 2021

Link: https://doi.org/10.1038/..

6

Effect of Dapagliflozin on Clinical Outcomes in Patients wi..:

McMurray, JJV ; Wheeler, DC ; Stefánsson, BV...
https://discovery.ucl.ac.uk/id/eprint/10116358/1/CIRCULATIONAHA.120.051675.pdf. , 2021

Link: https://discovery.ucl.ac..

7

Effects of dapagliflozin on mortality in patients with chro..:

Heerspink, HJL ; Sjöström, CD ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10126060/1/ehab094.pdf. , 2021

Link: https://discovery.ucl.ac..

8

Effects of Dapagliflozin in Patients With Kidney Disease, W..:

McMurray, JJV ; Wheeler, DC ; Stefánsson, BV...
https://discovery.ucl.ac.uk/id/eprint/10135686/1/1-s2.0-S2213177921003346-main.pdf. , 2021

Link: https://discovery.ucl.ac..

9

Safety and efficacy of dapagliflozin in patients with focal..:

Wheeler, DC ; Jongs, N ; Stefansson, BV...
https://discovery.ucl.ac.uk/id/eprint/10140531/1/gfab335.pdf. , 2021

Link: https://discovery.ucl.ac..

10

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease:

Chertow, GM ; Vart, P ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10140986/1/Wheeler_JASN-2021-02-0167.R2_AAM.pdf. , 2021

Link: https://discovery.ucl.ac..

11

Effects of dapagliflozin on major adverse kidney and cardio..:

Wheeler, DC ; Stefansson, B ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10122004/1/Wheeler_DAPA-CKD_Diabetes_and_CKD_aetiology_Revd_Ms_Clean_REVISED15OCT.pdf. , 2021

Link: https://discovery.ucl.ac..

12

A pre-specified analysis of the DAPA-CKD trial demonstrates..:

Wheeler, DC ; Toto, RD ; Stefansson, BV...
https://discovery.ucl.ac.uk/id/eprint/10127323/1/1-s2.0-S0085253821003963-main.pdf. , 2021

Link: https://discovery.ucl.ac..

13

Efficacy and Safety of Dapagliflozin by Baseline Glycemic S..:

Persson, F ; Rossing, P ; Vart, P...
https://discovery.ucl.ac.uk/id/eprint/10131359/17/Wheeler_DAPA-CKD_A1c_Diabetes%20Care_R1_revised_clean.pdf. , 2021

Link: https://discovery.ucl.ac..

14

The dapagliflozin and prevention of adverse outcomes in chr..:

Wheeler, DC ; Stefansson, BV ; Batiushin, M...
https://discovery.ucl.ac.uk/id/eprint/10109768/1/gfaa234.pdf. , 2020

Link: https://discovery.ucl.ac..

15

Dapagliflozin in Patients with Chronic Kidney Disease:

Heerspink, HJL ; Stefánsson, BV ; Correa-Rotter, R...
https://discovery.ucl.ac.uk/id/eprint/10111476/1/nejmoa2024816.pdf. , 2020

Link: https://discovery.ucl.ac..